Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study (MESCAMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02239393
Recruitment Status : Completed
First Posted : September 12, 2014
Last Update Posted : March 4, 2020
Sponsor:
Information provided by (Responsible Party):
Ottawa Hospital Research Institute